Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jilin Jinfukang Pharmaceutical is a pharmaceutical manufacturing company based in Meihekou, Jilin Province, China. Established in 2001, the company specializes in the production of Traditional Chinese Medicines (TCM) and Western chemical generic drugs across various dosage forms, including tablets, capsules, and granules. Its product portfolio is notably strong in respiratory health, pain management, and musculoskeletal treatments, with its Compound Liquorice Tablets being a widely recognized product in the Chinese market. The company operates large-scale, GMP-certified manufacturing facilities and focuses primarily on the domestic healthcare sector in China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jilin Jinfukang Pharmaceutical.